EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Investigation of genetic sex‐specific molecular profile in well‐differentiated thyroid cancer: Is there a difference between females and males?

Grégoire B Morand iD, Idit Tessler iD, Josh Krasner, Marc P Pusztaszeri, Tzahi Yamin, Nir A Gecel, Galit Avior, Richard J Payne

Clinical Otolaryngology · 2023-09 · 48 (5) · 748-755

DOI: 10.1111/coa.14075 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Otolaryngology, online erschienen am 22.05.2023. Verfasst von Grégoire B Morand und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Jewish General Hospital, McGill University, Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Mutation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Although more common in females, thyroid cancer is deemed to be more aggressive in males. The reasons for sex disparities in thyroid cancer are not well understood. We hypothesised that differences in molecular mutations between females and males contribute to this phenomenon.

Methods

Retrospective multicentre multinational study of thyroid nodules that underwent preoperative molecular profiling between 2015 and 2022. The clinical characteristics and mutational profiles of tumours in female and male patients were compared. Collected data included demographics, cytology results, surgical pathology, and molecular alterations.

Results

A total of 738 patients were included of which 571 (77.4%) were females. The extrathyroidal extension was more common in malignancies in males (chi‐squared, p = 0.028). The rate of point mutations and gene fusions were similar in both sex groups ( p > 0.05 for all mutations). Patients with nodules with BRAF V600E mutations were significantly younger than BRAF wild‐type nodule patients ( t ‐test, p = 0.0001). Conversely, patients with TERT promoter mutations were significantly older than patients with wild‐type TERT ( t ‐test, p < 0.0001). For patients harbouring both BRAF V600E and TERT mutations, the difference in age at presentation was significantly different in females ( t ‐test, p = 0.009) but not in males ( t ‐test, p = 0.433). Among females, patients with BRAF V600E and TERT mutations were significantly older than their wild‐type or single‐mutation counterpart ( t ‐test, p = 0.003).

Conclusion

The absolute rate of molecular mutations was similar in females and males. We found that extrathyroidal extension was more common in males. Moreover, BRAF V600E and TERT mutations occur at a younger age in males than in females. These two findings are factors that may explain the tendency of more aggressive disease in males.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsMutationHumansMaleFemaleRetrospective StudiesMiddle AgedSex FactorsAdultAgedProto-Oncogene Proteins B-rafTelomeraseGenetic Profile

Stichwörter der Autor:innen

hormonesmutationradiation exposurethyroid neoplasmsthyroid nodule

Substanzen

Proto-Oncogene Proteins B-rafTelomeraseBRAF protein, human

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.
  • Department of Otorhinolaryngology-Head and Neck Surgery, Luzerner Kantonsspital, Lucerne, Switzerland.
  • University of Zurich, Zurich, Switzerland.
  • Department of Otolaryngology-Head and Neck Surgery, Sheba Medical Center, Tel-Aviv University, Tel-Aviv, Israel.
  • Department of Pathology, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.
  • Department of Otolaryngology-Head and Neck Surgery, Sheba Medical Center, Technion University, Tel-Aviv, Israel.

ORCID-Profile: Grégoire B Morand, Idit Tessler

Zitieren

APA

Morand, G. B., Tessler, I., Krasner, J., Pusztaszeri, M. P., Yamin, T., Gecel, N. A., Avior, G., & Payne, R. J. (2023). Investigation of genetic sex‐specific molecular profile in well‐differentiated thyroid cancer: Is there a difference between females and males?. Clinical Otolaryngology, 48(5), 748-755. https://doi.org/10.1111/coa.14075

Vancouver

Morand GB, Tessler I, Krasner J, Pusztaszeri MP, Yamin T, Gecel NA, et al. Investigation of genetic sex‐specific molecular profile in well‐differentiated thyroid cancer: Is there a difference between females and males?. Clinical Otolaryngology. 2023;48(5):748-755. doi:10.1111/coa.14075

BibTeX
@article{Morand2023,
  author = {Morand, Grégoire B and Tessler, Idit and Krasner, Josh and Pusztaszeri, Marc P and Yamin, Tzahi and Gecel, Nir A and Avior, Galit and Payne, Richard J},
  title = {Investigation of genetic sex‐specific molecular profile in well‐differentiated thyroid cancer: Is there a difference between females and males?},
  journal = {Clinical Otolaryngology},
  year = {2023},
  volume = {48},
  number = {5},
  pages = {748--755},
  doi = {10.1111/coa.14075}
}
Kostenlos starten →